Interview with Matt Coffey, CEO of Oncolytics Biotech $ONCY

Benzinga

•

January 13th, 2022

DESCRIPTION

Interview with Matt Coffey, CEO of Oncolytics ($ONCY) about the significance of pelareorep! Oncolytics Biotech Inc. is a company in the process of developing pelareorep. Pelareorep is a immunotherapeutic agent that activates the "innately adaptive" quality of immune systems. It also weakens tumor defense mechanisms. Pelareorep is safe and tolerable to the immune system, increasing a system's ability to ward off cancer as well as increase the effectiveness of various oncology treatments through its weakening of a tumor's defense.

Benzinga

Benzinga delivers fast, actionable financial news and market insights to help investors stay ahead of the curve. From breaking market headlines and earnings coverage to expert analysis on stocks, options, futures, crypto, and macro trends, Benzinga connects audiences with the information that moves markets. Our video content features real-time market commentary, educational segments, and exclusive interviews with industry leaders—designed for active traders, long-term investors, and anyone looking to better understand the financial landscape.